These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1526012)

  • 21. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
    Ferrario CM; Averill DB; Brosnihan KB; Chappell MC; Iskandar SS; Dean RH; Diz DI
    Kidney Int; 2002 Oct; 62(4):1349-57. PubMed ID: 12234305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.
    Zisman LS; Abraham WT; Meixell GE; Vamvakias BN; Quaife RA; Lowes BD; Roden RL; Peacock SJ; Groves BM; Raynolds MV
    J Clin Invest; 1995 Sep; 96(3):1490-8. PubMed ID: 7657820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for existence of angiotensins I and II in mature renin granules from rat kidney cortex.
    Kawamura M; Nakamaru M; Inagami T
    Biochem Biophys Res Commun; 1985 Sep; 131(2):628-33. PubMed ID: 3902012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
    Clark KL; Robertson MJ; Drew GM
    Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensinogen is cleaved to angiotensin in isolated rat blood vessels.
    Hilgers KF; Hilgenfeldt U; Veelken R; Muley T; Ganten D; Luft FC; Mann JF
    Hypertension; 1993 Jun; 21(6 Pt 2):1030-4. PubMed ID: 8505088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. True versus immunoreactive angiotensin II in human plasma.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    Hypertension; 1985; 7(3 Pt 2):I1-7. PubMed ID: 2987122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct release of angiotensins I and II from isolated rat kidney perfused with angiotensinogen-free medium.
    Mizuno K; Higashimori K; Imada T; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):475-81. PubMed ID: 3322277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
    Hvistendahl JJ; Pedersen TS; Djurhuus JC; Pedersen EB; Frøkiaer J
    Urol Res; 2002 Jul; 30(3):169-77. PubMed ID: 12111180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatography for the separation of angiotensin and its metabolites in human plasma and sweat.
    Hermann K; Ring J; Phillips MI
    J Chromatogr Sci; 1990 Oct; 28(10):524-8. PubMed ID: 2246350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog.
    Rosivall L; Rinder DF; Champion J; Khosla MC; Navar LG; Oparil S
    Am J Physiol; 1983 Sep; 245(3):F408-15. PubMed ID: 6311028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial-venous determinations of the "immunoreactive" angiotensin peptides in human subjects.
    Reams GP; Souther M; Parisi M; Van Stone JC; Bauer JH
    J Lab Clin Med; 1989 Jun; 113(6):749-52. PubMed ID: 2732621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substrate-dependent angiotensin II formation in the peripheral circulation.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Life Sci; 1990; 46(5):335-41. PubMed ID: 1689447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats.
    Hermann K; McDonald W; Unger T; Lang RE; Ganten D
    J Physiol (Paris); 1984; 79(6):471-80. PubMed ID: 6100310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatographic-radioimmunoassay method for the measurement of angiotensin II peptides in human plasma.
    Souther ME; Lumpkin RH; Kuo KC; Reams GP; Bauer JH; Gehrke CW
    J Chromatogr; 1987 Jun; 417(1):27-40. PubMed ID: 3624401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats.
    Fox J; Guan S; Hymel AA; Navar LG
    Am J Physiol; 1992 May; 262(5 Pt 2):F902-9. PubMed ID: 1317125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Converting enzyme inhibition and renal tissue angiotensin II in the rat.
    Allan DR; McKnight JA; Kifor I; Coletti CM; Hollenberg NK
    Hypertension; 1994 Oct; 24(4):516-22. PubMed ID: 8088921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of urinary angiotensin to challenges of the renin-angiotensin system.
    Boer P; Vos PF; Koomans HA; Rabelink AJ; Beutler JJ; Dorhout Mees EJ
    Clin Chim Acta; 1991 Jun; 199(2):195-204. PubMed ID: 1873917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular renin in the guinea pig. Suppression by the renin inhibitor remikiren.
    Hilgers KF; Fischli W; Veelken R; Mann JF
    Hypertension; 1994 Jun; 23(6 Pt 2):861-4. PubMed ID: 8206619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and purification of angiotensin II using affinity and high-pressure liquid chromatography.
    Hermann K; Kimura B; Phillips MI
    Anal Biochem; 1986 Dec; 159(2):295-302. PubMed ID: 3826617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay of unprocessed sheep blood extracts to follow angiotensin metabolism.
    Osborn EC; Mackenzie JC; Rigby GV; Wilton A; Sugden PL
    Am J Physiol; 1977 Oct; 233(4):H527-34. PubMed ID: 910970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.